Monopar Therapeutics (MNPR) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 44 days, typically, give or take 21 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Thu, Nov 12, 2026before open 43 8-K
Q2 FY2026Wed, Aug 12, 2026during market hours 43 8-K
Q1 FY2026Thu, May 14, 2026during market hours 44 8-K
Q4 FY2025Fri, Mar 27, 2026during market hours 86 8-K
Q3 FY2025Thu, Nov 13, 2025before open 44 8-K
Q2 FY2025Tue, Aug 12, 2025before open 43 8-K
Q1 FY2025Tue, May 13, 2025before open 43 8-K
Q4 FY2024Mon, Mar 31, 2025before open 90 8-K

What they guided beta

Q3 FY2026 "Monopar expects its current funds to support operations through at least March 31, 2028, including: (1) regulatory and potential commercial activities for ALXN1840; (2) continued development of MNPR-101 programs; and (3) internal research and development." exhibit
Q3 FY2026 "The increase is attributed to interest earned on U.S. Treasury securities and commercial paper and to higher bank balances in 2026 due to the net proceeds of approximately $91.9 million from the September 2025 capital raise." exhibit
Q3 FY2026 "Kent is leading the Company’s medical affairs organization as Monopar prepares for potential U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA) for ALXN1840; that the Company is on track to complete the NDA submission within the next several weeks; and that Monopar expects its current funds to support operations through at least March 31, 2028." exhibit
Q2 FY2026 "Monopar expects its current funds to support operations through at least December 31, 2027, including: (1) regulatory and potential commercial activities for ALXN1840; (2) continued development of MNPR-101 programs; and (3) internal research and development." exhibit
Q2 FY2026 "The increase is attributed to interest earned on U.S. Treasury securities and commercial paper and to higher bank balances in 2026 due to the net proceeds of approximately $91.9 million from the September 2025 capital raise." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/MNPR
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/MNPR

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

MNPR earnings date badge

HTML

<a href="https://veritasdata.dev/company/MNPR/"><img src="https://veritasdata.dev/embed/MNPR.svg" alt="MNPR earnings date" width="240" height="56"></a>

Markdown

[![MNPR earnings date](https://veritasdata.dev/embed/MNPR.svg)](https://veritasdata.dev/company/MNPR/)

Script

<script async src="https://veritasdata.dev/embed/MNPR.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/MNPR"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.